BlueStem Wealth Partners’s Boston Scientific BSX Stock Holding History

BlueStem Wealth Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$778K	Buy	17,825 +179	+1%	+$8.29K	0.08%	71
2026 Q2	$753K	Buy	17,646 +90	+0.5%	+$4.89K	0.08%	69
2026 Q1	$1.1M	Buy	17,556 +49	+0.3%	+$3.92K	0.12%	60
2025 Q4	$1.67M	Sell	17,507 -273	-2%	-$26.8K	0.18%	49
2025 Q3	$1.74M	Sell	17,780 -212	-1%	-$22K	0.2%	42
2025 Q2	$1.93M	Buy	17,992 +1,704	+10%	+$172K	0.24%	38
2025 Q1	$1.64M	Sell	16,288 -356	-2%	-$35.8K	0.22%	37
2024 Q4	$1.49M	Buy	+16,644	New	+$1.47M	0.2%	42

Other funds holding BSX

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return

BlueStem Wealth Partners's BSX Position: Q3 2026 in Review

BlueStem Wealth Partners increased its Boston Scientific (BSX) stake by 1% in Q3 2026, buying an estimated $8.29K and bringing the position to 17,825 shares worth $778K. The position accounts for 0.08% of the portfolio, ranked #71.

BlueStem Wealth Partners first reported a position in BSX in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.93M in Q2 2025. 1,274 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

BlueStem Wealth Partners held 17,825 shares of Boston Scientific worth $778K as of Q3 2026.
BlueStem Wealth Partners bought 179 Boston Scientific shares in Q3 2026, an estimated $8.29K.
Boston Scientific made up 0.08% of BlueStem Wealth Partners's portfolio in Q3 2026, its #71 holding.
BlueStem Wealth Partners first reported a position in Boston Scientific in Q4 2024 and has held it in 8 quarters since.
BlueStem Wealth Partners's Boston Scientific position peaked at $1.93M in Q2 2025.
1,274 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on BlueStem Wealth Partners's 13F filing for Q3 2026, filed 13 Nov 2026.